litlas
Log inCreate account

Ivan Borrello

Active 1988–2025

64
Papers
19,950
Citations
52
h-index
63
i10-index

Citations

Citations per year for Ivan Borrello1979: 1 citations1988: 3 citations1989: 10 citations1990: 19 citations1991: 12 citations1992: 14 citations1993: 6 citations1994: 11 citations1995: 10 citations1996: 7 citations1997: 12 citations1998: 14 citations1999: 30 citations2000: 43 citations2001: 39 citations2002: 48 citations2003: 47 citations2004: 53 citations2005: 42 citations2006: 69 citations2007: 110 citations2008: 154 citations2009: 175 citations2010: 176 citations2011: 182 citations2012: 182 citations2013: 200 citations2014: 178 citations2015: 326 citations2016: 345 citations2017: 332 citations2018: 328 citations2019: 813 citations2020: 875 citations2021: 823 citations2022: 531 citations2023: 410 citations2024: 524 citations2025: 212 citations2026: 5 citations1980–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,916 citing papers, 30.2% of this breakdownChina: 975 citing papers, 10.1% of this breakdownGermany: 596 citing papers, 6.2% of this breakdownItaly: 564 citing papers, 5.8% of this breakdownFrance: 470 citing papers, 4.9% of this breakdownUnited Kingdom: 453 citing papers, 4.7% of this breakdownJapan: 336 citing papers, 3.5% of this breakdownSpain: 324 citing papers, 3.3% of this breakdownCanada: 265 citing papers, 2.7% of this breakdownNetherlands: 263 citing papers, 2.7% of this breakdownAustralia: 183 citing papers, 1.9% of this breakdownSwitzerland: 181 citing papers, 1.9% of this breakdown
0%30.2%Other 22.1%

Institutions

Fields

  • Medicine61.9%
  • Immunology and Microbiology26.8%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Neuroscience0.7%
  • Engineering0.6%
  • Computer Science0.2%
  • Other0.7%

Topics

  • Cancer Immunotherapy and Biomarkers9.6%
  • Immune Cell Function and Interaction8%
  • Immunotherapy and Immune Responses6.3%
  • Immune cells in cancer6.2%
  • CAR-T cell therapy research5.8%
  • Hematopoietic Stem Cell Transplantation4.6%
  • Other59.5%

Coauthors

All papers

Open in search
  1. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

    Authors: Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C. Scott, Martin Gutierrez, Stephen J. Schuster, Michael Millenson, Deepika Cattry, Gordon J. Freeman, Scott J. Rodig, Bjoern Chapuy, Azra H. Ligon, Lili Zhu, Joseph F. Grosso, Su Young Kim, John M. Timmerman, Margaret A. Shipp, Philippe Armand - New England Journal of Medicine 2014 cited by 3,547

  2. HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    Authors: Leo Luznik, Paul V. O’Donnell, Heather J. Symons, Allen Chen, M. Susan Leffell, Marianna Zahurak, Ted Gooley, S Piantadosi, Michele Kaup, Richard F. Ambinder, Carol Ann Huff, William Matsui, Javier Bolaños‐Meade, Ivan Borrello, Jonathan D. Powell, Elizabeth B. Harrington, S. Warnock, Mary E.D. Flowers, Robert A. Brodsky, Brenda M. Sandmaier, Rainer Storb, Richard J. Jones, Ephraim J. Fuchs - Biology of Blood and Marrow Transplantation 2008 cited by 1,906

  3. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

    Authors: Alexander M. Lesokhin, Stephen M. Ansell, Philippe Armand, Emma Scott, Ahmad Halwani, Martin Gutierrez, Michael Millenson, Adam D. Cohen, Stephen J. Schuster, Daniel Lebovic, Madhav V. Dhodapkar, David Avigan, Bjoern Chapuy, Azra H. Ligon, Gordon J. Freeman, Scott J. Rodig, Deepika Cattry, Lili Zhu, Joseph F. Grosso, M. Brigid Garelik, Margaret A. Shipp, Ivan Borrello, John M. Timmerman - Journal of Clinical Oncology 2016 cited by 1,011

  4. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

    Authors: Paolo Serafini, Kristen F. Meckel, Michael J. Kelso, Kimberly Noonan, Joseph A. Califano, Wayne M. Koch, Luigi Dolcetti, Vincenzo Bronte, Ivan Borrello - The Journal of Experimental Medicine 2006 cited by 754

  5. Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

    Authors: Rajani Ravi, Kimberly Noonan, Vui Pham, Rishi Bedi, Alex Zhavoronkov, Ivan V. Ozerov, Eugene Makarev, Artem V. Artemov, Piotr Wysocki, Ranee Mehra, Sridhar Nimmagadda, Luigi Marchionni, David Sidransky, Ivan Borrello, Evgeny Izumchenko, Atul Bedi - Nature Communications 2018 cited by 329

  6. CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity

    Authors: Meisam Naeimi Kararoudi, Yuya Nagai, Ezgi Elmas, Marcelo de Souza Fernandes Pereira, Syed Abbas Ali, Philip Imus, Darren Wethington, Ivan Borrello, Dean A. Lee, Gabriel Ghiaur - Blood 2020 cited by 126

  7. Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells

    Authors: Paolo Serafini, Stephanie Mgebroff, Kimberly Noonan, Ivan Borrello - Cancer Research 2008 cited by 665

  8. Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma

    Authors: Donald T. Weed, Jennifer L. Vella, Isildinha M. Reis, Adriana C. De La Fuente, Carmen Gómez, Zoukaa Sargi, Ronen Nazarian, Joseph A. Califano, Ivan Borrello, Paolo Serafini - Clinical Cancer Research 2014 cited by 256

  9. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

    Authors: Christiane Meyer, Alexandra Sevko, Marcel Ramacher, Alexandr V. Bazhin, Christine S. Falk, Wolfram Osen, Ivan Borrello, Masashi Kato, Dirk Schadendorf, Michal Baniyash, Viktor Umansky - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 342

  10. Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma

    Authors: Joseph A. Califano, Zubair Khan, Kimberly Noonan, Lakshmi Rudraraju, Zhe Zhang, Hao Wang, Steven N. Goodman, Christine G. Gourin, Patrick K. Ha, Carole Fakhry, John Saunders, Marshall Levine, Mei San Tang, Geoffrey Neuner, Jeremy D. Richmon, Ray Blanco, Nishant Agrawal, Wayne M. Koch, Shanthi Marur, Donald T. Weed, Paolo Serafini, Ivan Borrello - Clinical Cancer Research 2015 cited by 184

  11. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

    Authors: Leo Luznik, Javier Bolaños‐Meade, Marianna Zahurak, Allen Chen, B. Douglas Smith, Robert A. Brodsky, Carol Ann Huff, Ivan Borrello, William Matsui, Jonathan D. Powell, Yvette L. Kasamon, Steven N. Goodman, Allan D. Hess, Hyam I. Levitsky, Richard F. Ambinder, Richard J. Jones, Ephraim J. Fuchs - Blood 2010 cited by 404

  12. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

    Authors: Amy E. DeZern, Marianna Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina D. Wagner‐Johnston, Richard F. Ambinder, Leo Luznik, Javier Bolaños‐Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky - Blood Advances 2020 cited by 149

  13. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

    Authors: Giovanna Gallina, Luigi Dolcetti, Paolo Serafini, Carmela De Santo, Ilaria Marigo, Mario P. Colombo, Giuseppe Basso, Frank Brombacher, Ivan Borrello, Paola Zanovello, Silvio Bicciato, Vincenzo Bronte - Journal of Clinical Investigation 2006 cited by 785

  14. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

    Authors: Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel, Hua-Ling Tsai, Javier Bolaños‐Meade, Gary L. Rosner, Christopher G. Kanakry, Karlo Perica, Heather J. Symons, Robert A. Brodsky, Douglas E. Gladstone, Carol Ann Huff, Keith W. Pratz, Gabrielle T. Prince, Amy E. DeZern, Ivana Gojo, William Matsui, Ivan Borrello, Michael A. McDevitt, Lode J. Swinnen, B. Douglas Smith, Mark J. Levis, Richard F. Ambinder, Leo Luznik, Richard J. Jones, Ephraim J. Fuchs, Yvette L. Kasamon - Blood 2015 cited by 300

  15. Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

    Authors: Yvette L. Kasamon, Javier Bolaños‐Meade, Gabrielle T. Prince, Hua-Ling Tsai, Shannon R. McCurdy, Jennifer A. Kanakry, Gary L. Rosner, Robert A. Brodsky, Karlo Perica, B. Douglas Smith, Douglas E. Gladstone, Lode J. Swinnen, Margaret M. Showel, William Matsui, Carol Ann Huff, Ivan Borrello, Keith W. Pratz, Michael A. McDevitt, Ivana Gojo, Amy E. DeZern, Satish Shanbhag, Mark J. Levis, Leo Luznik, Richard F. Ambinder, Ephraim J. Fuchs, Richard J. Jones - Journal of Clinical Oncology 2015 cited by 239

  16. Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression

    Authors: Paolo Serafini, Ivan Borrello, Vincenzo Bronte - Seminars in Cancer Biology 2005 cited by 763

  17. A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies

    Authors: Philippe Armand, Alexander M. Lesokhin, Ivan Borrello, John M. Timmerman, Martin Gutierrez, Lili Zhu, Mihaela Popa McKiver, Stephen M. Ansell - Leukemia 2020 cited by 110

  18. High-Dose Granulocyte-Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response through the Recruitment of Myeloid Suppressor Cells

    Authors: Paolo Serafini, Rebecca Carbley, Kimberly Noonan, Gladys Tan, Vincenzo Bronte, Ivan Borrello - Cancer Research 2004 cited by 515

  19. A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma

    Authors: Kimberly Noonan, Luigi Marchionni, Judy M. Anderson, Drew M. Pardoll, G. David Roodman, Ivan Borrello - Blood 2010 cited by 209

  20. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

    Authors: Kevin F. Staveley-O’Carroll, Eduardo M. Sotomayor, Jami Montgomery, Ivan Borrello, Leon Hwang, Steve Fein, Drew M. Pardoll, Hyam I. Levitsky - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 696

  21. Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

    Authors: William Matsui, Qiuju Wang, James Barber, Sarah Brennan, B. Douglas Smith, Ivan Borrello, Ian McNiece, Lan Lin, Richard F. Ambinder, Craig D. Peacock, D. Neil Watkins, Carol Ann Huff, Richard J. Jones - Cancer Research 2008 cited by 538

  22. Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting

    Authors: Vasileios Karantalis, Darcy L. DiFede, Gary Gerstenblith, Si M. Pham, James F. Symes, Juan P. Zambrano, Joel E. Fishman, Pradip M. Pattany, Ian McNiece, John V. Conte, Steven P. Schulman, Kathérine C. Wu, Ashish S. Shah, Elayne Breton, Janice Davis‐Sproul, Richard P. Schwarz, Gary Feigenbaum, Muzammil Mushtaq, Viky Y. Suncion, Albert C. Lardo, Ivan Borrello, Adam Mendizabal, Tomer Z. Karas, John Byrnes, Maureen H. Lowery, Alan W. Heldman, Joshua M. Hare - Circulation Research 2014 cited by 350

  23. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide

    Authors: Shannon R. McCurdy, Yvette L. Kasamon, Christopher G. Kanakry, Javier Bolaños‐Meade, Hua-Ling Tsai, Margaret M. Showel, Jennifer A. Kanakry, Heather J. Symons, Ivana Gojo, B. Douglas Smith, Maria Bettinotti, William Matsui, Amy E. DeZern, Carol Ann Huff, Ivan Borrello, Keith W. Pratz, Douglas E. Gladstone, Lode J. Swinnen, Robert A. Brodsky, Mark J. Levis, Richard F. Ambinder, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik - Haematologica 2016 cited by 188

  24. Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial

    Authors: Javier Bolaños‐Meade, Kenneth R. Cooke, Christopher Gamper, Syed Abbas Ali, Richard F. Ambinder, Ivan Borrello, Ephraim J. Fuchs, Douglas E. Gladstone, Christian B. Gocke, Carol Ann Huff, Leo Luznik, Lode J. Swinnen, Heather J. Symons, Stephanie A. Terezakis, Nina D. Wagner‐Johnston, Richard J. Jones, Robert A. Brodsky - The Lancet Haematology 2019 cited by 154